{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:05:33Z","timestamp":1759017933318,"version":"3.44.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.annder.2009.02.007","type":"journal-article","created":{"date-parts":[[2009,6,27]],"date-time":"2009-06-27T04:36:10Z","timestamp":1246077370000},"page":"795-799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Succ\u00e8s de l\u2019association rituximab\u2013cortico\u00efdes g\u00e9n\u00e9raux dans le traitement d\u2019une \u00e9pidermolyse bulleuse acquise r\u00e9calcitrante"],"prefix":"10.1016","volume":"136","author":[{"given":"A.","family":"Cavailhes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Balme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Skowron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2009.02.007_bib1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0733-8635(18)30249-3","article-title":"Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. Diseases of autoimmunity to type VII collagen","volume":"11","author":"Gammon","year":"1993","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.annder.2009.02.007_bib2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/1523-1747.ep12526124","article-title":"Epidermolysis bullosa acquisita: ultrastructural and immunological studies","volume":"76","author":"Yaoita","year":"1981","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2009.02.007_bib3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/1523-1747.ep12285634","article-title":"Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita","volume":"108","author":"Chen","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2009.02.007_bib4","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.0022-202X.2005.23702.x","article-title":"Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita","volume":"124","author":"Woodley","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2009.02.007_bib5","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1023\/A:1026451530967","article-title":"Autoantibodies to type VII collagen have heterogeneous subclass and light chain compositions and their complement-activating capacities do not correlate with the inflammatory clinical phenotype","volume":"20","author":"Gandhi","year":"2000","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.annder.2009.02.007_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5070\/D3630287FK","article-title":"A quick and simple serum test to differentiate bullous pemphigoid, epidermolysis bullosa acquisita, and anti-epiligrin cicatricial pemphigoid","volume":"14","author":"Liu","year":"2008","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.annder.2009.02.007_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/1523-1747.ep12480369","article-title":"The subclass distribution of IgG autoantibodies in cicatricial pemphigoid and epidermolysis bullosa acquisita","volume":"97","author":"Bernard","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2009.02.007_bib8","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1067\/mjd.2001.113693","article-title":"Emerging treatment for epidermolysis bullosa acquisita","volume":"44","author":"Engineer","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2009.02.007_bib9","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa067752","article-title":"A single cycle of rituximab for the treatment of severe pemphigus","volume":"357","author":"Joly","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2009.02.007_bib10","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archderm.143.8.1033","article-title":"Treatment of severe pemphigus with rituximab: report of 12\u00a0cases and a review of the literature","volume":"143","author":"Cianchini","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2009.02.007_bib11","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0151-9638(07)78259-5","article-title":"Rituximab: Mabthera","volume":"134","author":"Lapeyre","year":"2007","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2009.02.007_bib12","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(01)06573-4","article-title":"Treatment of childhood autoimmune haemolytic anaemia with rituximab","volume":"358","author":"Quartier","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.annder.2009.02.007_bib13","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1002\/1529-0131(200112)44:12<2836::AID-ART471>3.0.CO;2-W","article-title":"Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy","volume":"44","author":"Specks","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.annder.2009.02.007_bib14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1001\/archderm.143.2.192","article-title":"Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab","volume":"143","author":"Niedermeier","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2009.02.007_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/archderm.142.2.147","article-title":"Successful adjuvant treatment of recalcitrant epidermolysis bullosa acquisita with anti-CD20 antibody rituximab","volume":"142","author":"Schmidt","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2009.02.007_bib16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1365-2133.2006.07596.x","article-title":"A successful therapeutic trial of rituximab in the treatment of a patient with recalcitrant, high-titre epidermolysis bullosa acquisita","volume":"156","author":"Crichlow","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2009.02.007_bib17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000106585","article-title":"Epidermolysis bullosa acquisita following bullous pemphigoid, successfully treated with the anti-CD20 monoclonal antibody rituximab","volume":"215","author":"Wallet-Faber","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2009.02.007_bib18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2133.2007.08048.x","article-title":"Treatment-resistant classical epidermolysis bullosa acquisita responding to rituximab","volume":"157","author":"Sadler","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2009.02.007_bib19","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1468-3083.2006.02127.x","article-title":"Fatal Pseudomonas pneumonia following rituximab therapy in a patient with epidermolysis bullosa acquisita","volume":"21","author":"Mercader","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2009.02.007_bib20","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jaad.2004.06.007","article-title":"Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab)","volume":"51","author":"Morrison","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2009.02.007_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/archderm.140.1.91","article-title":"Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody)","volume":"140","author":"Dupuy","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2009.02.007_bib22","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1067\/mjd.2002.126273","article-title":"Anti-CD20 chimeric monoclonal antibody (rituximab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris with implications in the pathogenesis of the disorder","volume":"47","author":"Salopek","year":"2002","journal-title":"J Am Acad Dermatol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963809002622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963809002622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:55:55Z","timestamp":1758970555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963809002622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0151963809002622"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2009.02.007","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Succ\u00e8s de l\u2019association rituximab\u2013cortico\u00efdes g\u00e9n\u00e9raux dans le traitement d\u2019une \u00e9pidermolyse bulleuse acquise r\u00e9calcitrante","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2009.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}